Buchbinder SP - Search Results

1

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.

Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Montefiori DC, Tomaras GD, McElrath MJ, Hural J, Graham BS, Jin X; HVTN 083 Study Group and the NIAID HVTN. Walsh SR, et al. Among authors: buchbinder sp. J Infect Dis. 2016 Feb 15;213(4):541-50. doi: 10.1093/infdis/jiv496. Epub 2015 Oct 15. J Infect Dis. 2016. PMID: 26475930 Free PMC article. Clinical Trial.

2

Herpes zoster and human immunodeficiency virus infection.

Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmberg SD. Buchbinder SP, et al. J Infect Dis. 1992 Nov;166(5):1153-6. doi: 10.1093/infdis/166.5.1153. J Infect Dis. 1992. PMID: 1308664

3

Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.

Lifson AR, Buchbinder SP, Sheppard HW, Mawle AC, Wilber JC, Stanley M, Hart CE, Hessol NA, Holmberg SD. Lifson AR, et al. Among authors: buchbinder sp. J Infect Dis. 1991 May;163(5):959-65. doi: 10.1093/infdis/163.5.959. J Infect Dis. 1991. PMID: 1673465

4

Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.

Hadler SC, Judson FN, O'Malley PM, Altman NL, Penley K, Buchbinder S, Schable CA, Coleman PJ, Ostrow DN, Francis DP. Hadler SC, et al. J Infect Dis. 1991 Mar;163(3):454-9. doi: 10.1093/infdis/163.3.454. J Infect Dis. 1991. PMID: 1825315 Clinical Trial.

5

Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS.

Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Katz MH, et al. Among authors: buchbinder sp. J Infect Dis. 1994 Jul;170(1):198-202. doi: 10.1093/infdis/170.1.198. J Infect Dis. 1994. PMID: 8014498

6

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

Harrer E, Harrer T, Barbosa P, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer E, et al. J Infect Dis. 1996 Feb;173(2):476-9. doi: 10.1093/infdis/173.2.476. J Infect Dis. 1996. PMID: 8568316

7

T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.

Kalams SA, Johnson RP, Dynan MJ, Hartman KE, Harrer T, Harrer E, Trocha AK, Blattner WA, Buchbinder SP, Walker BD. Kalams SA, et al. Among authors: buchbinder sp. J Exp Med. 1996 Apr 1;183(4):1669-79. doi: 10.1084/jem.183.4.1669. J Exp Med. 1996. PMID: 8666925 Free PMC article.

8

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: buchbinder sp. AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585. AIDS Res Hum Retroviruses. 1996. PMID: 8743084

9

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: buchbinder sp. J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327

10

Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate.

Buchbinder SP, Douglas JM Jr, McKirnan DJ, Judson FN, Katz MH, MacQueen KM. Buchbinder SP, et al. J Infect Dis. 1996 Nov;174(5):954-61. doi: 10.1093/infdis/174.5.954. J Infect Dis. 1996. PMID: 8896495 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters